NIKA PHARMACEUTICALS, INC.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $-23.6K | $399 |
| FY2022 | — | $-17.3K | $864 |
| FY2023 | — | $-82.1K | $19.6K |
| FY2024 | — | $-221.2K | $2.1K |
| FY2025 | — | $-297.6K | $1.9K |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $-23.6K | $399 |
| FY2022 | — | $-17.3K | $864 |
| FY2023 | — | $-82.1K | $19.6K |
| FY2024 | — | $-221.2K | $2.1K |
| FY2025 | — | $-297.6K | $1.9K |